Basic Amlodipine Information

• INN (International Nonproprietary Name): Amlodipine
• Brand Names Available In Australia: Norvasc, APO-Amlodipine
• ATC Code: C08CA01
• Forms & Dosages: Tablets commonly 2.5mg, 5mg, 10mg; oral solution 1mg/ml in limited markets; fixed combinations with valsartan, perindopril or atorvastatin also available
• Manufacturers In Australia: Pfizer (Norvasc) and Apotex (APO-Amlodipine) are listed in market data
• Registration Status In Australia: Registered and available under Norvasc and other brands as of November 2025
• OTC / Rx Classification: Prescription Only (Rx) in major markets including Australia

Latest Research Highlights

Worried whether amlodipine still measures up against newer blood-pressure drugs?

Recent pharmacoepidemiology from 2022–2025 in Australia and international meta-analyses continue to show reliable reductions in systolic and diastolic blood pressure with amlodipine.

The drug’s long half-life gives durable 24-hour coverage compared with short-acting dihydropyridines, which supports once-daily dosing and better adherence.

Real-world registries have reported consistent drops in angina frequency and good tolerability in older cohorts taking amlodipine.

Pooled safety data identify peripheral oedema, headache and flushing as the commonest adverse events, and these are generally dose-related.

TGA and EMA post-marketing summaries up to late 2025 report no new major safety signals for amlodipine.

Practical monitoring advice from regulators and product data emphasises home blood-pressure checks and watching for ankle swelling.

Below is a concise outcomes versus safety table summarising the recent evidence and regulatory observations.

Clinical Effectiveness In Australia

Do Australian doctors still reach for amlodipine for everyday hypertension and angina?

PBS utilisation analyses and outcome studies in Australia show amlodipine is an effective first-line dihydropyridine calcium-channel blocker for hypertension and chronic stable angina.

Effectiveness is enhanced when amlodipine is combined with ACE inhibitors or ARBs, where improved blood-pressure control and quality-of-life measures are commonly reported.

International randomised trials also support cardiovascular event reduction when amlodipine is part of combination therapy, consistent with real-world Australian practice.

TGA adverse-event reports in the same period align with global patterns, with most signals dose-related and non-serious.

Access and pharmacy counselling are central to clinical effectiveness in Australia, with community pharmacists supporting adherence and monitoring.

Primary care frequently uses telehealth scripts and community pharmacies such as Chemist Warehouse, Priceline and TerryWhite to dispense amlodipine and advise patients.

Urban patients commonly have easy access to BP monitors, while rural and remote patients may rely on nurse-led clinics or outreach services for follow-up.

Indications And Expanded Uses

What is amlodipine officially used for, and when is off‑label care considered?

TGA-approved indications include hypertension and chronic stable or vasospastic angina, and these remain the main, evidence-backed uses in Australia.

International literature also documents selective off-label paediatric use from around age 6 years in specialist settings with doses typically 2.5–5mg once daily.

Clinical trials show symptomatic benefit in vasospasm and improved exercise tolerance for stable angina, but amlodipine is not indicated for acute coronary syndromes.

Australian prescribers generally adhere to TGA indications, with off‑label paediatric prescriptions managed by paediatric cardiology or specialists when required.

Standard adult dosing typically starts at 5mg once daily with maintenance 5–10mg once daily, while children 6–17 years may receive 2.5–5mg once daily under specialist care.

Shared decision-making and clear documentation in shared care plans are recommended, particularly when treating Indigenous families where culturally appropriate counselling is essential.

Composition And Brand Landscape

Which brands and formulations of amlodipine will a patient commonly see in Australia?

Amlodipine is a dihydropyridine calcium-channel blocker classified under ATC C08CA01 and produced globally in multiple branded and generic formulations.

In Australia the principal market listings include Norvasc (Pfizer) and APO-Amlodipine (Apotex), with tablets commonly in 5mg and 10mg strengths.

Packaging in pharmacy listings usually features blister packs of 10–100 tablets and occasional bottled presentations in some markets.

Pharmacists routinely advise patients on bioequivalence when switching between brands and explain packaging differences that may affect adherence.

A short table below maps Australian brands to strengths and manufacturers for easy reference.

Contraindications And Special Precautions

Who should not take amlodipine, or who needs closer monitoring?

Absolute contraindications include known hypersensitivity to amlodipine or dihydropyridines, severe hypotension, shock including cardiogenic shock, obstructive left-ventricular outflow tract lesions such as severe aortic stenosis, and haemodynamically unstable post‑MI heart failure.

Relative precautions include severe hepatic impairment, severe heart failure, frail elderly patients and those with significant comorbidities.

Australian care must factor in higher comorbidity burdens among Indigenous, rural and aged-care populations, and clinicians should screen for liver disease where relevant.

Driving and machinery warnings apply if dizziness occurs, and patients should be counselled about these risks.

Recommended monitoring frequency in high-risk groups is summarised below to aid clinicians and pharmacists in follow-up planning.

Dosage Guidelines

How should amlodipine be started and adjusted for different patients?

Typical adult initiation is 5mg once daily with maintenance between 5–10mg once daily depending on response and tolerability.

Lower initial doses such as 2.5mg or starting at 5mg are recommended for elderly patients and those with hepatic impairment, with slow titration.

Paediatric dosing for children aged 6–17 years in specialist settings is usually 2.5–5mg once daily, and use in children under 6 years is not recommended.

Steady state is generally reached in 7–8 days, supporting simple once-daily regimens for adherence.

No routine renal adjustment is required, but caution is advised and monitoring is appropriate in significant renal impairment.

Missed-dose advice is to take the dose as soon as remembered unless it is near the time for the next dose, and do not double up.

Interactions Overview

Which medicines, foods or drinks might change how amlodipine works?

Amlodipine is metabolised largely by CYP3A4, so strong CYP3A4 inhibitors such as clarithromycin and some azole antifungals can raise plasma levels and increase hypotension risk.

Co-administration with other antihypertensives increases the risk of symptomatic hypotension and requires dose review and monitoring.

There is a clinically relevant interaction with simvastatin in some jurisdictions, where a simvastatin maximum of 20mg is recommended when used with amlodipine.

Alcohol can potentiate hypotension and dizziness and patients should be counselled to avoid heavy drinking until they know how amlodipine affects them.

Grapefruit products may affect CYP3A4 and warrant caution, and pharmacists should screen e-scripts and My Health Record for interacting medicines.

A compact drug-interaction table below helps clinicians and pharmacists apply practical actions at the point of care.

Cultural Perceptions And Patient Habits

What do Australians actually think about taking amlodipine long-term?

Community surveys and patient forums show people value once-daily medicines, clear cost information and practical pharmacist advice when starting drugs like amlodipine.

Brand recognition such as Norvasc can influence confidence, but many Australians choose PBS-subsidised generics to reduce out-of-pocket cost.

Trust in community pharmacists is high, and pharmacies play a central role in adherence support, especially for rural and Indigenous communities through outreach and culturally appropriate counselling.

Telehealth prescribing has improved access but can fragment care unless patients register with a local pharmacy and keep an updated medication list.

Short, plain-language explanations and translated materials or interpreter access are often needed for better health literacy in diverse communities.

Availability And Pricing Patterns

How easy is it to get amlodipine in Australia and what will it cost?

Market listings confirm Norvasc and APO-Amlodipine are present in Australia, with tablet strengths commonly stocked as 5mg and 10mg in blister packs.

PBS subsidy status historically covers many amlodipine generics and strongly influences retail pricing and dispensing volumes at community pharmacies.

Chemist Warehouse, Priceline and TerryWhite Chemmart commonly supply PBS or private prescriptions and compete on price for private-pay customers.

Rural patients may face higher private costs or occasional supply delays, but community pharmacies and outreach services typically mitigate these issues.

For convenience, in our online pharmacy amlodipine is available without a prescription, with discreet delivery to Australia in 5-14 days.

Patients should check PBS eligibility, concession pricing and pharmacy vouchers where applicable before purchase.

Comparable Medicines And Preferences

How does amlodipine stack up against other calcium-channel blockers and blood-pressure classes?

Comparative trials place amlodipine among preferred dihydropyridine CCBs alongside nifedipine, felodipine and lercanidipine for hypertension, while non-dihydropyridines like verapamil offer different heart-rate effects.

Choice between classes depends on comorbidity: ACE inhibitors are preferred where renal protection is a concern, and some CCBs are chosen when patients cannot tolerate ACE inhibitors or ARBs.

Amlodipine’s once-daily dosing and broad availability on PBS make it a common, cost-conscious option for many Australian patients.

Some alternatives such as lercanidipine may have lower rates of peripheral oedema in certain trials, but availability, PBS listing and patient tolerance guide local prescribing choices.

Where high cardiovascular risk exists—especially in Indigenous patients—shared decision-making should balance affordability, side effects and clinical benefit.

Frequently Asked Questions

Is amlodipine on the PBS and affordable?

Many amlodipine generics are PBS-listed; check the current PBS schedule and speak with your pharmacist about substitution and concession pricing.

Can I drink alcohol while taking amlodipine?

Moderate alcohol may increase dizziness and hypotension risk; avoid heavy drinking and avoid driving or dangerous tasks until you know how it affects you.

Will amlodipine make my ankles swell?

Peripheral oedema is a common, dose-related side effect; discuss dose reduction, switching classes or combination therapy with your prescriber if it becomes troublesome.

What about pregnancy or breastfeeding?

Amlodipine is generally avoided in pregnancy unless the treating team judge benefits outweigh risks; consult your obstetric team for personalised advice.

Where can I find more regulatory consumer information?

Refer to TGA and PBS consumer leaflets for the latest local guidance and safety information.

Guidelines For Proper Use (Pharmacist Counselling)

What should a pharmacist tell a patient starting amlodipine to improve safety and adherence?

Explain indication clearly, start-dose (typically 5mg once daily), expected duration (chronic therapy for hypertension or angina) and time to steady state (about 7–8 days).

Advise on missed-dose rules: take as soon as remembered unless near the next dose, and do not double up.

Discuss common side effects—peripheral oedema, headache, flushing and dizziness—and when to seek urgent care for red-flag signs like syncope or severe hypotension.

Recommend home blood-pressure monitoring where possible and a follow-up BP check within 1–2 weeks of initiation or dose change for higher-risk patients.

Use culturally safe language and translated resources for Indigenous and CALD patients, and arrange follow-up via telehealth or local clinic if needed.

• Red Flag Symptoms: severe dizziness, fainting, rapid heart rate, signs of allergic reaction
• Storage: store below 25°C and keep tablets in original packaging

Delivery Across Australia

Practical Takeaways

Patients commonly ask whether amlodipine will control blood pressure all day, and the long half-life supports once-daily dosing and steady BP control.

Monitor ankles for swelling and record home blood-pressure readings to show your clinician at review appointments.

If peripheral oedema or bothersome side effects occur, discuss dose adjustment or alternative classes with the prescriber rather than stopping suddenly.

Pharmacists should verify interactions, counsel about alcohol and grapefruit caution, and use My Health Record where available to reconcile medicines.

For cost-conscious patients, discuss PBS options and generic substitution to reduce out-of-pocket costs while maintaining therapeutic equivalence.

Culturally appropriate counselling and outreach services help close access gaps for rural and Indigenous patients and support ongoing adherence.